12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.3% to $10.19 during Tuesday’s pre-market session. The market value…
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Kineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers ARCA biopharma (NASDAQ:ABIO) shares moved upwards by 84.8% to $3.16 during Wednesday’s regular session. The market value…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Apollomics (NASDAQ:APLM) stock rose 10.9% to $0.61 during Tuesday’s after-market session. The market value of their outstanding…
BioSig Technologies Announces That It Has Terminated A Significant Number Of Its Employees And Expects To Substantially Reduce Business Operations
BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a significant number of its employees and expects to substantially reduce business
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Applied Therapeutics (NASDAQ:APLT) stock rose 42.5% to $5.34 during Monday’s regular session. The market value of their…
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers BioSig Technologies (NASDAQ:BSGM) stock increased by 7.7% to $0.96 during Monday’s after-market session. The company’s market cap…
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.
Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
BioSig Adds Five New Patent Awards To 100+ Total Patent Portfolio Covering Digital Signal Processing Technology And AI
BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company") a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, announced today